EUVIMEDEUVIMED entdecken
Crossref

Impact of Prostate Size on the Functional and Oncological Outcomes of Robot-assisted Radical Prostatectomy

Abdel Rahman Jaber, Marcio Covas Moschovas, Shady Saikali, Ahmed Gamal, Roshane Perera, Travis Rogers, Ela Patel, Marco Sandri, Derya Tilki, Vipul Patel

European Urology Focus · 2024-03 · 10 (2) · 263-270

DOI: 10.1016/j.euf.2024.01.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Urology Focus, 2024-03. Verfasst von Abdel Rahman Jaber und 9 weiteren Autor:innen. Beteiligte Einrichtung: AdventHealth Global Robotics Institute, Celebration, FL, USA. Electronic address: asjaber@hotmail.com. Hauptthemen laut MEDLINE: Prostatectomy, Robotic Surgical Procedures, Prostatic Neoplasms, Prostate. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVE: Robot-assisted radical prostatectomy (RARP) is the main surgical approach for treatment of prostate cancer in the USA. Prostate size is always depicted as a factor affecting the outcomes of RARP as shown by many studies, but these studies are limited to a small number of patients. Our aim was to evaluate functional and oncologic outcomes of RARP across varying prostate size measured as prostate specimen weight. METHODS: A cohort of 14 481 patients who underwent RARP in a single center was divided into four groups according to prostate specimen weight: group 1, 150 g. Perioperative and postoperative variables and pathological and functional outcomes were compared among the four groups. Cumulative incidence functions were plotted to visualize the distribution of event-time variables among the groups, and differences were evaluated using the log-rank test. KEY FINDINGS AND LIMITATIONS: Patients with larger prostates (groups 3 and 4) were more likely to have higher prostate-specific antigen (PSA), lower biopsy grade group, and worse baseline urinary and sexual characteristics. Group 4 had lower rates of full nerve-sparing surgery (13.7% vs 38.3%) and lymph node dissection (51.3% vs 71.4%), more pT2 disease (69.8% vs 60.3%), less pT3 disease (30.2% vs 39.7%), and lower rates of positive surgical margins (12.8% vs 19.3%) and biochemical recurrence (5.9% vs 7.5%) than group 1. Finally, we observed differences in functional outcomes among the groups for greater prostate size, and patients in group 4 had worse rates of urinary continence (77.8% vs 89.5%) and recovery of sexual function (70.0% vs 84.1%) than group 1. Our study is limited by its retrospective design. CONCLUSIONS AND CLINICAL IMPLICATIONS: The results demonstrate that in this large cohort of patients, greater prostate size affects multiple outcomes, including the rate of nerve-sparing surgery, potency and continence recovery, and oncological and pathological outcomes. These data will be valuable when counseling patients regarding possible RARP outcomes and the timeline for recovery. PATIENT SUMMARY: Our study shows that prostate size can affect the outcomes of robot-assisted removal of the prostate for patients with prostate cancer. Larger prostate size can be associated with worse functional outcomes after surgery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProstatectomyRobotic Surgical ProceduresProstatic NeoplasmsProstateHumansMaleMiddle AgedOrgan SizeAgedTreatment OutcomeRetrospective StudiesOrgan Sparing TreatmentsProstate-Specific Antigen

Stichwörter der Autor:innen

Prostate sizeRadical prostatectomyRobot-assisted surgery

Substanzen

Prostate-Specific Antigen

Autor:innen und Institutionen

  • AdventHealth Global Robotics Institute, Celebration, FL, USA. Electronic address: asjaber@hotmail.com.
  • AdventHealth Global Robotics Institute, Celebration, FL, USA; University of Central Florida, Orlando, FL, USA.
  • AdventHealth Global Robotics Institute, Celebration, FL, USA.
  • Big and Open Data Innovation Laboratory, University of Brescia, Brescia, Italy.
  • Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany.

Zitieren

APA

Jaber, A. R., Moschovas, M. C., Saikali, S., Gamal, A., Perera, R., Rogers, T., Patel, E., Sandri, M., Tilki, D., & Patel, V. (2024). Impact of Prostate Size on the Functional and Oncological Outcomes of Robot-assisted Radical Prostatectomy. European Urology Focus, 10(2), 263-270. https://doi.org/10.1016/j.euf.2024.01.007

Vancouver

Jaber AR, Moschovas MC, Saikali S, Gamal A, Perera R, Rogers T, et al. Impact of Prostate Size on the Functional and Oncological Outcomes of Robot-assisted Radical Prostatectomy. European Urology Focus. 2024;10(2):263-270. doi:10.1016/j.euf.2024.01.007

BibTeX
@article{Jaber2024,
  author = {Jaber, Abdel Rahman and Moschovas, Marcio Covas and Saikali, Shady and Gamal, Ahmed and Perera, Roshane and Rogers, Travis and Patel, Ela and Sandri, Marco and Tilki, Derya and Patel, Vipul},
  title = {Impact of Prostate Size on the Functional and Oncological Outcomes of Robot-assisted Radical Prostatectomy},
  journal = {European Urology Focus},
  year = {2024},
  volume = {10},
  number = {2},
  pages = {263--270},
  doi = {10.1016/j.euf.2024.01.007}
}
Kostenlos starten →